Replies to post #126568 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Great news


If any of the cell tests had failed we might have had to go back to the beginning and start over.

With paperwork, we just need to finalize it and we can quickly edit any part of it which isn’t perfect.

And the paperwork is being done by our contractors. All specialists and probably faster than our team.

The great risk of cell, caps and freezing failures are now behind us.

These reproducible cells have passee all required fda tests now.

This is now 90% risk off on today’s news.

Paperwork is easy to fix. The great risk that the cells wouldn’t pass muster is now behind us.

Well done Pharmacyte and Austrianova.